GenSight Biologics. (SIGHT.PA) Q3 2025 Earnings

29SepConfirmed
Q3 2024
Q1 2025
Q3 2025
Q3 2025
-0.07
-0.06
-0.06
-0.05

Details

Expected EPS
N/A
Actual EPS
-0.050207111789999995
Surprise EPS
-0.05
Surprise Percent
+∞%

Description

GenSight Biologics. (SIGHT.PA) has reported earnings of -0.050207111789999995 per share for Q3 2025.

0 Comments

Share your thoughts